ASO Author Reflections: Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?
Mohammad Saad Farooq, Giorgos C. Karakousis
Springer Nature ·
2025-09-17
· DOI 10.1245/s10434-025-18373-8
The publisher did not provide an abstract — full text is available via the link below.
Mohammad Saad Farooq, Giorgos C. Karakousis. ASO Author Reflections: Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?. // Annals of Surgical Oncology. – 2025. – DOI: 10.1245/s10434-025-18373-8. – URL: https://doi.org/10.1245/s10434-025-18373-8
Mohammad Saad Farooq & Giorgos C. Karakousis (2025). ASO Author Reflections: Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-025-18373-8
Mohammad Saad Farooq and Giorgos C. Karakousis. “ASO Author Reflections: Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?.” Annals of Surgical Oncology, 2025. doi:10.1245/s10434-025-18373-8.
@article{Farooq2025,
title = {ASO Author Reflections: Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?},
author = {Farooq, Mohammad Saad and Karakousis, Giorgos C.},
journal = {Annals of Surgical Oncology},
year = {2025},
doi = {10.1245/s10434-025-18373-8},
url = {https://doi.org/10.1245/s10434-025-18373-8}
}